-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Teva Pharmaceutical Industries Ltd annual Current Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Teva Pharmaceutical Industries Ltd annual Current Income Tax Expense (Benefit) for 2023 was $333M, a 22.6% decline from 2022.
- Teva Pharmaceutical Industries Ltd annual Current Income Tax Expense (Benefit) for 2022 was $430M, a 59.3% increase from 2021.
- Teva Pharmaceutical Industries Ltd annual Current Income Tax Expense (Benefit) for 2021 was $270M, a 48.4% increase from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)